|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-5-4
|
|
pubmed:abstractText |
Treatment with peginterferon alfa and ribavirin produces a sustained virologic response (SVR) in approximately 60% of hepatitis C virus (HCV)-infected patients. Alternate options are needed for patients who relapse or do not respond to therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1528-0012
|
|
pubmed:author |
pubmed-author:AlbrechtJaniceJ,
pubmed-author:BedossaPierreP,
pubmed-author:BergThomasT,
pubmed-author:BrassCliffordC,
pubmed-author:BruixJordiJ,
pubmed-author:BurroughsMargaretM,
pubmed-author:CarrilhoFlairF,
pubmed-author:ColomboMassimoM,
pubmed-author:CraxiAntonioA,
pubmed-author:DiagoMoisesM,
pubmed-author:Epic Study Group,
pubmed-author:FlammStevenS,
pubmed-author:GonçalesFernandoF,
pubmed-author:GriffelLouisL,
pubmed-author:HeathcoteE JennyEJ,
pubmed-author:McGarrityThomasT,
pubmed-author:Moreno-OteroRicardoR,
pubmed-author:MukhopadhyayPabakP,
pubmed-author:PoynardThierryT,
pubmed-author:SchiffEugeneE,
pubmed-author:SchmidtWarrenW,
pubmed-author:SilvaMarceloM,
pubmed-author:TergRubenR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
136
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1618-28.e2
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19208349-Antiviral Agents,
pubmed-meshheading:19208349-Drug Therapy, Combination,
pubmed-meshheading:19208349-Female,
pubmed-meshheading:19208349-Hepacivirus,
pubmed-meshheading:19208349-Hepatitis C, Chronic,
pubmed-meshheading:19208349-Humans,
pubmed-meshheading:19208349-Interferon-alpha,
pubmed-meshheading:19208349-Male,
pubmed-meshheading:19208349-Middle Aged,
pubmed-meshheading:19208349-Polyethylene Glycols,
pubmed-meshheading:19208349-RNA, Viral,
pubmed-meshheading:19208349-Recombinant Proteins,
pubmed-meshheading:19208349-Ribavirin,
pubmed-meshheading:19208349-Treatment Failure
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.
|
|
pubmed:affiliation |
Service d'hepatologie, Université Pierre et Marie Curie Liver Center, Hôpital La Pitié Salpêtrière, Paris, France. tpoynard@teaser.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
